Compare PEPG & MGPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PEPG | MGPI |
|---|---|---|
| Founded | 2018 | 1941 |
| Country | United States | United States |
| Employees | N/A | 267 |
| Industry | Biotechnology: Pharmaceutical Preparations | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 353.9M | 398.0M |
| IPO Year | 2022 | 1994 |
| Metric | PEPG | MGPI |
|---|---|---|
| Price | $4.89 | $18.29 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 5 |
| Target Price | $11.67 | ★ $30.00 |
| AVG Volume (30 Days) | ★ 683.6K | 362.8K |
| Earning Date | 03-04-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 2.58% |
| EPS Growth | ★ 25.61 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $19,782,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $5.11 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.89 | $16.45 |
| 52 Week High | $7.80 | $33.75 |
| Indicator | PEPG | MGPI |
|---|---|---|
| Relative Strength Index (RSI) | 41.17 | 40.92 |
| Support Level | $4.24 | N/A |
| Resistance Level | $5.50 | $26.44 |
| Average True Range (ATR) | 0.42 | 0.72 |
| MACD | -0.10 | 0.31 |
| Stochastic Oscillator | 18.64 | 66.40 |
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed that their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle, and the central nervous system. Its pipeline products are: PGN-EDO51, PGN-EDODM1, and others.
MGP Ingredients Inc is a producer and supplier of distilled spirits, specialty wheat protein, and starch food ingredients based in the United States. It operates in three reportable segments: Distillery Solutions, Branded Spirits Segment, and Ingredient Solutions. Maximum revenue is generated from the Branded Spirits segment, which consists of a portfolio of brands that it produces through its distilleries and bottling facilities and sells to distributors or to state governments that directly control the sale of alcohol. MGP's branded spirits include various brands across numerous categories and price tiers, such as Penelope Bourbon, Yellowstone Bourbon, Minor Case Straight Rye Whiskey, Brady's Irish Cream, Exotico Tequila, Arrow Cordials, Canada House Canadian Whisky, Lady Bligh Rum, etc.